License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: January 27, 2023
Last Modified: September 09, 2023
Protocol Integer ID: 75979
Keywords: RNA, RNA Extraction, SARS-CoV-2, Zymo, COVID-19, RT-PCR, Virus, Nasopharyngeal specimen, Viral Transport Medium, rna viral kit, nasopharyngeal specimen, amplification of sar, fever, infection, allplex 2019ncov assay kit, rna, global pandemic, global pandemic by the world health organization, sar
Disclaimer
This is an optimised protocol for SARS-CoV-2 RNA isolation and amplification using Zymo Quick-RNA Viral Kit (200 prep) and Allplex 2019nCoV Assay Kit. The authors do not accept any liability for the collection and handling of both samples and reagents, results from the use of the protocol and its interpretation as well as any errors or omissions that may be made. The reader should make his/her own evaluation as to the appropriateness of the procedures described.
Abstract
COVID-19 caused by the SARS-CoV-2 was declared a global pandemic by the World Health Organization in March 2020. Classical symptoms associated with the infection include fever, cough, chills, headache, and muscle aches amongst others. To effectively diagnose the infection and contain its spread, efficient diagnostic tools are required. The current gold standard for the confirmation of SARS-CoV-2 infection is RT-PCR, this protocol outlines procedures for the isolation and amplification of SARS-CoV-2 RNA from Nasopharyngeal specimens using the Zymo Quick-RNA Viral Kit and Allplex 2019nCoV Assay Kit respectively.
Automatic micropipette (10 μL, 20 μL, 200 μL and 1000μL)
RT-PCR
Allplex 2019nCoV Assay Kit (Seegen Inc., Korea)
1.5 mL - 2.0 mL tube ice rack
0.2 mL PCR tube ice rack
Consumables
0.5 - 10 μL filtered micropipette tips
2 - 20 μL filtered micropipette tips
20 - 200 μL filtered micropipette tips
100 - 1000 μL filtered micropipette tips
1.5 mL microcentrifuge tubes
Viral Transport Medium (Shanghai Focusgen Biotechnology Co., Ltd, China)
96 well qPCR plate and plate cover
Equipment
Centrifuge
Vortex
Biosafety Cabinet II
Bio-Rad CFX 1000 series
Safety warnings
1. Perform all RNA isolation procedures in a Level II Biosafety Cabinet
2. Wear the appropriate PPEs before, during, and after the isolation and amplification of the SARS-CoV-2 RNA while still in the laboratory.
3. Dithiothreitol causes skin and eye irritation. Handle with care
4. Handle all reagents and specimens as potentially hazardous materials
Before start
1. DTT is not stable in solution. Only freshly-made DTT solutions should be used
2. Aliquot the needed volume of reagents from the stock for the procedure to prevent contamination of the large reagent stock.
3. Allow the amplification kit to thaw completely in a 4°C fridge, before preparing the PCR master mix. Avoid centrifuging the reagents to defrost them.
4. Decontaminate all workspace with 1% bleach followed by 70% alcohol
Reagent Preparation - Viral RNA Wash Buffer
To each bottle of 48 mL of RNA Wash Buffer (concentrate) add 192 mL of molecular grade ethanol (95-100%).
Invert the reagent bottle several times and label with the date of preparation
Reagent Preparation - Viral RNA Buffer
Weigh 0.75 g of dithiothreitol (DTT) into 15 mL of nuclease-free water
Allow the pellets to dissolve completely.
Add 12 mL of the freshly prepared DTT solution to the 100 mL Viral RNA Buffer (concentrate). Invert several times to mix completely.
Note
Invert the reagent bottle gently to avoid over-frothing the reagent. Allow the reconstituted reagent to sit at room temperature for 60 seconds before use.
Cycling Conditions: Reverse transcription at 50°C for 20 minutes, followed by an initial denaturation at 95°C for 15 minutes and 45 cycles of 94°C for 15 seconds and 58°C for 30 seconds (plate read: data acquisition)
Fluorophores: FAM (E gene), Cal Red 610 (RdRP gene), Quasar 670 (N gene), and HEX (Internal Control).